Protean BioDiagnostic’s CEO Dr. Anthony Magliocco MD will be speaking at the European Annual Meeting on Multiplex Histopathology, on September 12th at Montpellier.
The meeting is centered around the possibilities of Multiplex Histopathology in phenotyping and physiopathological mechanisms, and in aiding our understanding of major diseases.